However, other studies demonstrate a tumor-suppressive role of DGCR5 in lung cancer (Chen et al., 2017; Luo et al., 2018), gastric cancer (Xu et al., 2019), bladder cancer (Fang et al., 2019), and cervical cancer (Liu et al., 2019). The gene discussed is DGCR5; the disease is urinary bladder carcinoma.